Fabien M.

Fabien M. has a diverse work experience in the field of biotechnology and cell therapy. Fabien currently holds the position of Chief Development Officer at TreeFrog Therapeutics since January 2020, where they previously served as the Interim Chief Operating Officer from January 2018 to January 2020.

Prior to TreeFrog Therapeutics, Fabien M. was involved with several other companies. Fabien was a Scientific Advisory Board Member at GOLIVER THERAPEUTICS starting from January 2019, and prior to that, they served as a Strategic Committee member & Cell Therapy industrialization consultant from May 2017 to January 2019.

Fabien M. also had a role as a Cell and Gene Therapy Industrialization Expert - Consultant at BIP partners from May 2017 to present. Additionally, they co-founded and served as the Chief Technology Officer at Cell-Easy from May 2017 to January 2020.

In terms of previous experiences, Fabien M. worked as a Consultant - GMP Process at Flash Therapeutics from March 2018 to December 2018. Fabien held various roles at Pall Life Sciences, including Head of EMEA Bioprocess Services from December 2015 to April 2017, and Head of Cell Culture Services from November 2014 to December 2015.

Before joining Pall Life Sciences, Fabien M. worked at ATMI as a Senior Application Specialist - Cell Culture Lab Associate from October 2012 to November 2014, and as an Application Specialist from November 2010 to October 2012.

Fabien M. began their career as a Scientist at Artelis from February 2009 to November 2010, and prior to that, they worked as a Junior Scientist from September 2008 to February 2009.

During their early career, Fabien M. gained internship experiences at GlaxoSmithKline Biologicals from July 2007 to February 2008, and at Protein biosensor from July 2006 to August 2006, where they were involved in recombinant protein production for algal toxin detection.

Overall, Fabien M. has demonstrated expertise in various aspects of biotechnology, cell therapy industrialization, and GMP processes throughout their career.

Fabien M. began their education in 2003 at a preparatory school in Toulouse. After completing their studies there in 2005, they enrolled at ENSTBB Bordeaux INP, where they pursued a Master's Degree in Biotechnology. Fabien successfully completed their master's program in 2008.